Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Spironolactone plus finasteride reduces hirsutism more effectively.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Researchers found a new way to create hair-growing structures in the lab that can grow hair when put into mice.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Melatonin may help treat PCOS symptoms in rats.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.